All eyes on the Federal Reserve

Published 14-MAR-2017 16:39 P.M.


1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

US markets lacked direction but changed little ahead of tomorrow’s Federal Reserve meeting that most are expecting will result in an interest rate increase.

The Dow spent most of the day in negative territory before closing at 20,881 points, representing a decline of 0.1%.

The NASDAQ put in a better performance, starting on its previous day’s close of 5861 points before tracking up to close near its intraday high of 5877 points, representing a gain of 0.2%.

European markets were buoyed by solid increases in most base metals, but tended to plateau out leading up to the close of US markets.

Notwithstanding that trend there was a strong lead from Rio Tinto plc with its shares rallying nearly 4%.

The FTSE 100 closed at 7367 points, up 0.3%.

While other European markets finished in positive territory the gains weren’t as substantial with the DAX up 0.2% and the Paris CAC 40 gaining 0.1%.

The oil price was relatively flat, hovering in the vicinity of US$48.50 a barrel.

There was also little movement in the gold price as it closed at US$1203 per ounce.

Elsewhere on the commodities front, nickel was the standout performer, increasing from the previous day’s close of US$4.45 per pound to close in the vicinity of US$4.60 per pound. Zinc and copper were both up by about 1%.

The Australian dollar is currently fetching just above US$0.755.

While all the talk will be on the Fed Reserve’s interest rate decision, there will be some interesting local data released today in the way of the NAB Business Confidence report.

February retail sales figures coming out of China will also be of interest as they cycle against a relatively strong 10.4% in January.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free